a8324m
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2024
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
EXHIBIT INDEX
|
Exhibit Number
|
Description
|
|
99.1
|
01
May 2024 - Directorate
Change
|
99.1
Haleon plc announces changes to the Board
1 May 2024: Haleon
plc (the "Company" or "Haleon") (LSE/NYSE:
HLN) today
announces that following Deirdre Mahlan's appointment
as President,
Chief Executive Officer and Chairperson of the Board of The
Duckhorn Portfolio, Inc. (NYSE: NAPA), Deirdre will be stepping
down from her role as Non-Executive Director and Chair of the Audit
& Risk Committee of Haleon. Deirdre has agreed to continue as
Non-Executive Director and Chair of the Audit & Risk Committee
of Haleon until a successor has been
identified.
Sir Dave Lewis, Haleon's Chair commented: "On
behalf of the Board, I would like to thank Deirdre for her
considerable contributions to the Board and for chairing the Audit
& Risk Committee. I wish her all the best for the future. A
search for her successor is now underway."
Contacts
Zoë
Bird
+44 7736 746167
Sonya Ghobrial +44 7392
784784
Email: corporate.media@haleon.com
About Haleon
Haleon (LSE / NYSE: HLN) is a global leader in consumer health,
with a purpose to deliver better everyday health with humanity.
Haleon's product portfolio spans five major categories - Oral
Health, Pain Relief, Respiratory Health, Digestive Health and
Other, and Vitamins, Minerals and Supplements (VMS). Its
long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren,
Theraflu, Otrivin, Polident, parodontax and Centrum - are built on
trusted science, innovation and deep human
understanding.
For more information, please visit www.haleon.com.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
HALEON PLC
(Registrant)
|
|
Date: May 01,
2024
|
By:
|
/s/
Amanda Mellor
|
|
|
|
Name:
|
Amanda
Mellor
|
|
|
|
Title:
|
Company
Secretary
|
エドガーで原本を確認する